Intervention Protocol

Atomoxetine for Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents

  1. G Kannan Kallapiran1,*,
  2. Priya Mammen2,
  3. Prathap Tharyan3,
  4. Paul Russell2

Editorial Group: Cochrane Developmental, Psychosocial and Learning Problems Group

Published Online: 18 APR 2012

DOI: 10.1002/14651858.CD009804


How to Cite

Kallapiran GK, Mammen P, Tharyan P, Russell P. Atomoxetine for Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 4. Art. No.: CD009804. DOI: 10.1002/14651858.CD009804.

Author Information

  1. 1

    Children's Hospital Westmead, Psychological Medicine, Westmead, NSW, Australia

  2. 2

    Christian Medical College, Child & Adolescent Psychiatry, Vellore, TN, India

  3. 3

    Christian Medical College, South Asian Cochrane Network & Centre, Prof. BV Moses & ICMR Advanced Centre for Research & Training in Evidence Informed Health Care, Vellore, Tamil Nadu, India

*G Kannan Kallapiran, Psychological Medicine, Children's Hospital Westmead, Cnr Hawkesbury Rd & Hainsworth Street, Westmead, NSW, 2145, Australia. sgkkan@yahoo.co.in.

Publication History

  1. Publication Status: New
  2. Published Online: 18 APR 2012

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To determine the efficacy and safety of atomoxetine in the treatment of ADHD in children and adolescents.